Tourmaline Bio Announces Pricing of Public Offering of Common Stock

NEW YORK, Jan. 25, 2024 -- Tourmaline Bio, Inc. , a late-stage clinical biotechnology company developing transformative medicines to dramatically improve the lives of patients with life-altering...

Related Keywords

New York ,United States ,Piper Sandler ,Truist Securities Inc ,Equity Syndicate Prospectus Department ,Exchange Commission ,Guggenheim Securities ,Tourmaline Bio Inc ,Prospectus Department ,Equity Syndicate Department ,Piper Sandler Co ,Truist Securities ,Tourmaline Bio ,Private Securities Litigation Reform Act ,Quarterly Report ,Markets ,